17495-12-4 Usage
Classification
Purine derivative
Structure
Contains a pyrimidine ring fused to an imidazole ring
Applications
Pharmaceutical Research: Utilized in drug development
Potential Therapeutic Uses:
Anticancer drug design and synthesis
Antiviral drug development
Investigation for treating neurological disorders
Enzyme inhibition studies
Versatility
Suitable for biological and pharmacological studies
Check Digit Verification of cas no
The CAS Registry Mumber 17495-12-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,4,9 and 5 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 17495-12:
(7*1)+(6*7)+(5*4)+(4*9)+(3*5)+(2*1)+(1*2)=124
124 % 10 = 4
So 17495-12-4 is a valid CAS Registry Number.
17495-12-4Relevant articles and documents
SYNTHESIS OF GUANINE FROM 3-METHYLXANTHINE
Kochergin, P. M.,Persanova, L. V.,Aleksandrova, E. V.,Gutorov, L. A.,Korsunskii, V. S.
, p. 337 - 339 (1995)
A new preparative method of obtaining guanine from 3-methylxanthine has been developed.
NOVEL SUBSTITUTED XANTHINE DERIVATIVES
-
Page/Page column 38, (2019/01/30)
The present invention relates to substituted xanthine derivatives, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels.
SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
-
Page/Page column 382; 383, (2014/09/29)
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
